BIOMAT Database Logo BIOMAT Database Logo

Pyrimidine metabolism. III. The interaction of the catabolic and anabolic pathways of uracil metabolism. 1957

E S CANELLAKIS

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

E S CANELLAKIS
Anabolic and catabolic pathways of pyrimidine metabolism in rat liver.
January 1981, The International journal of biochemistry,
E S CANELLAKIS
Interaction between catabolic and anabolic steroids.
October 1970, Current therapeutic research, clinical and experimental,
E S CANELLAKIS
Anabolic and catabolic pathways regulating skeletal muscle mass.
May 2010, Current opinion in clinical nutrition and metabolic care,
E S CANELLAKIS
Heritable catabolic and anabolic disorders of lipid metabolism.
March 1977, Metabolism: clinical and experimental,
E S CANELLAKIS
Enzyme induction and repression in anabolic and catabolic pathways.
January 1967, Archiv fur Mikrobiologie,
E S CANELLAKIS
Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis.
October 1995, Acta orthopaedica Scandinavica. Supplementum,
E S CANELLAKIS
Anabolic and catabolic mediators.
May 1998, Current opinion in clinical nutrition and metabolic care,
E S CANELLAKIS
Anabolic and catabolic mediators.
May 1999, Current opinion in clinical nutrition and metabolic care,
E S CANELLAKIS
Deoxycytidine and 2',3'-dideoxycytidine metabolism in human monocyte-derived macrophages. A study of both anabolic and catabolic pathways.
December 1993, Biochemical and biophysical research communications,
E S CANELLAKIS
Sulfoglycolysis: catabolic pathways for metabolism of sulfoquinovose.
December 2021, Chemical Society reviews,
Copied contents to your clipboard!